Literature DB >> 22486713

Detection of BRCA1/2 mutations in breast cancer patients from Thailand and Pakistan.

J Ahmad, F Le Calvez-Kelm, S Daud, C Voegele, M Vallée, A Ahmad, N Kakar, J D McKay, V Gaborieau, M Léoné, O Sinilnikova, S Sangrajrang, S V Tavtigian, F Lesueur.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22486713     DOI： 10.1111/j.1399-0004.2012.01869.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN： 0009-9163            Impact factor:   4.438


× No keyword cloud information.
  4 in total

Review 1.  Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries.

Authors:  Ava Kwong; Vivian Y Shin; John C W Ho; Eunyoung Kang; Seigo Nakamura; Soo-Hwang Teo; Ann S G Lee; Jen-Hwei Sng; Ophira M Ginsburg; Allison W Kurian; Jeffrey N Weitzel; Man-Ting Siu; Fian B F Law; Tsun-Leung Chan; Steven A Narod; James M Ford; Edmond S K Ma; Sung-Won Kim
Journal:  J Med Genet       Date:  2015-07-17       Impact factor: 6.318

2.  Missense mutations (p.H371Y, p.D438Y) in gene CHEK2 are associated with breast cancer risk in women of Balochistan origin.

Authors:  Abdul Hameed Baloch; Shakeela Daud; Nafeesa Raheem; Muhammad Luqman; Adeel Ahmad; Abdul Rehman; Jameela Shuja; Saeeda Rasheed; Akhtar Ali; Naseebullah Kakar; Hafiz Khush Naseeb; Mohammad Alam Mengal; Muhammad Arif Awan; Muhammad Wasim; Dost Mohammad Baloch; Jamil Ahmad
Journal:  Mol Biol Rep       Date:  2014-01-04       Impact factor: 2.316

3.  Germline Mutation Analysis in Sporadic Breast Cancer Cases With Clinical Correlations.

Authors:  Sadia Ajaz; Sani-E-Zehra Zaidi; Saleema Ali; Aisha Siddiqa; Muhammad Ali Memon
Journal:  Front Genet       Date:  2022-03-09       Impact factor: 4.599

4.  Association between germline pathogenic variants and breast cancer risk in Japanese women: The HERPACC study.

Authors:  Yumiko Kasugai; Tomohiro Kohmoto; Yukari Taniyama; Yuriko N Koyanagi; Yoshiaki Usui; Madoka Iwase; Isao Oze; Rui Yamaguchi; Hidemi Ito; Issei Imoto; Keitaro Matsuo
Journal:  Cancer Sci       Date:  2022-03-07       Impact factor: 6.716
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.